L. Vo
Impact in
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Use and Resistance 2
-
- Diabetes Management and Education 1
- Co-authors
- Benjamin Alan Lipsky (3 shared papers)J. Weigelt (1 shared paper)Ying P. Tabak (1 shared paper)R.S. Johannes (1 shared paper)Ribhi M. Shawar (1 shared paper)Gunnar Sandström (1 shared paper)Paul R. Georghiou (1 shared paper)Rabih O. Darouiche (1 shared paper)
- Journals
- Value in Health (3 papers)Current Medical Research and Opinion (3 papers)Diagnostic Microbiology and Infectious Disease (2 papers)Diabetologia (1 paper)ESMO Open (1 paper)
- Partner nations
- United StatesUnited KingdomVietnam
In The Last Decade
L. Vo
13 papers receiving 427 citations
Peers
Comparison fields: 5 of 73
- Internal Medicine 20
- Clinical Biochemistry 38
- Gastroenterology 29
- Applied Microbiology and Biotechnology 10
- Rehabilitation 32
Countries citing papers authored by L. Vo
This map shows the geographic impact of L. Vo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Vo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Vo more than expected).
Fields of papers citing papers by L. Vo
This network shows the impact of papers produced by L. Vo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Vo. The network helps show where L. Vo may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Vo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 129 | |
| 2 | 1996 | 95 | |
| 3 | 2017 | 45 | |
| 4 | 2020 | 41 | |
| 5 | 2005 | 37 | |
| 6 | 2014 | 33 | |
| 7 | 2017 | 26 | |
| 8 | 2014 | 25 | |
| 9 | 2006 | 4 | |
| 10 | Comparison of major-bleeding risk and health care costs among treatment-naïve non-valvular atrial fibrillation patients initiating apixaban, dabigatran, rivaroxaban, or warfarin | 2015 | 2 |
| 11 | 2013 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2005 | 1 | |
| 15 | 2001 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2014 | 0 | |
| 18 | 2026 | 0 |
About L. Vo
L. Vo is a scholar working on Applied Microbiology and Biotechnology, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Cardiology and Cardiovascular Medicine and Family Practice, having authored 18 papers that have together received 442 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (3 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Antibiotic Use and Resistance (2 papers), Multiple and Secondary Primary Cancers (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Parasitic Infections and Diagnostics (1 paper) and Diabetes Management and Education (1 paper). The work is most often cited by research in Internal Medicine (20 citations), Clinical Biochemistry (38 citations), Gastroenterology (29 citations), Applied Microbiology and Biotechnology (10 citations) and Rehabilitation (32 citations). L. Vo has collaborated with scholars based in United States, United Kingdom and Vietnam. Frequent co-authors include Benjamin Alan Lipsky, J. Weigelt, Ying P. Tabak, R.S. Johannes, Ribhi M. Shawar, Gunnar Sandström, Paul R. Georghiou, Rabih O. Darouiche, Jill E. Clarridge and Lena M. Napolitano. Their work appears in journals such as Value in Health, Current Medical Research and Opinion, Diagnostic Microbiology and Infectious Disease, Diabetologia and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.